Summit Therapeutics SMMT
NASDAQ SMMT
$17.02 -0.81 (-4.54%)
As of: Nov 11, 2026 · 11:46 AM EST

Summit Therapeutics (SMMT) EV to CFO (2016 - 2017)

Updated

Summit Therapeutics' (SMMT) EV to CFO was 37.48 for FY2017.

Analysis

Summit Therapeutics (SMMT) EV to CFO (2016 - 2017) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Summit Therapeutics 14.26 Bn 11.63 Bn -
Historic Data

Historic Data

Download Data
DateValue
Oct 31, 2017 25.65
Jul 31, 2017 24.53
Apr 30, 2017 54.47
Oct 31, 2016 50.43
API Access

Summit Therapeutics EV to CFO API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ev-to-cfo&ticker=SMMT&period=max&api_key=YOUR_API_KEY